-
1
-
-
0021824648
-
Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin
-
Calandra, G. B., K. R. Brown, L. C. Grad, V. I. Ahonkkai, C. Wang, and M. A. Aziz. 1985. Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin. Am. J. Med. 78(Suppl. 6A): 73-78.
-
(1985)
Am. J. Med.
, vol.78
, Issue.SUPPL. 6A
, pp. 73-78
-
-
Calandra, G.B.1
Brown, K.R.2
Grad, L.C.3
Ahonkkai, V.I.4
Wang, C.5
Aziz, M.A.6
-
2
-
-
0023892181
-
Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: Experience with imipenem/cilastatin
-
Calandra, G. B., E. Lydick, J. Carrigan, L. Weiss, and H. Guess. 1988. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin. Am. J. Med. 84:911-918.
-
(1988)
Am. J. Med.
, vol.84
, pp. 911-918
-
-
Calandra, G.B.1
Lydick, E.2
Carrigan, J.3
Weiss, L.4
Guess, H.5
-
3
-
-
0022971332
-
The safety profile of imipenem/cilasatin: Worldwide clinical experience based on 3470 patients
-
Calandra, G. B., C. Wang, M. A. Aziz, and K. R. Brown. 1986. The safety profile of imipenem/cilasatin: worldwide clinical experience based on 3470 patients. J. Antimicrob. Chemother. 18(Suppl. E.):193-202.
-
(1986)
J. Antimicrob. Chemother.
, vol.18
, Issue.SUPPL. E
, pp. 193-202
-
-
Calandra, G.B.1
Wang, C.2
Aziz, M.A.3
Brown, K.R.4
-
4
-
-
0025171043
-
Determination of imipenem in human plasma, urine and tissue by high-performance liquid chromatography
-
Carlucci, G., L. Biordi, C. Vicentini, and M. Bologna. 1990. Determination of imipenem in human plasma, urine and tissue by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 8:283-286.
-
(1990)
J. Pharm. Biomed. Anal.
, vol.8
, pp. 283-286
-
-
Carlucci, G.1
Biordi, L.2
Vicentini, C.3
Bologna, M.4
-
5
-
-
0025114459
-
Central nervous system toxicity of quinolones: Human and animal findings
-
Christ, W. 1990. Central nervous system toxicity of quinolones: human and animal findings. J. Antimicrob. Chemother. 26(Suppl. B):219-225.
-
(1990)
J. Antimicrob. Chemother.
, vol.26
, Issue.SUPPL. B
, pp. 219-225
-
-
Christ, W.1
-
6
-
-
0031936583
-
Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: Correlation with the interaction at the Mu-opioid receptor
-
Cox, E. H., T. Kerbusch, P. H. Van Der Graaf, and M. Danhof. 1998. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the Mu-opioid receptor. J. Pharmacol. Exp. Ther. 284:1095-1103.
-
(1998)
J. Pharmacol. Exp. Ther.
, vol.284
, pp. 1095-1103
-
-
Cox, E.H.1
Kerbusch, T.2
Van Der Graaf, P.H.3
Danhof, M.4
-
7
-
-
0021276082
-
Kinetics of drug action in disease states. 1. Effect of infusion rate on phenobarbital concentrations in serum, brain and cerebrospinal fluid of normal rats at onset of loss of righting reflex
-
Danhof, M., and G. Levy. 1984. Kinetics of drug action in disease states. 1. Effect of infusion rate on phenobarbital concentrations in serum, brain and cerebrospinal fluid of normal rats at onset of loss of righting reflex. J. Pharmacol. Exp. Ther. 229:44-50.
-
(1984)
J. Pharmacol. Exp. Ther.
, vol.229
, pp. 44-50
-
-
Danhof, M.1
Levy, G.2
-
8
-
-
0028965803
-
Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem/cilastatin and meropenem
-
Day, I. P., J. Goudie, K. Nishiki, and P. D. Williams. 1994. Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem/cilastatin and meropenem. Toxicol. Lett. 76:239-243.
-
(1994)
Toxicol. Lett.
, vol.76
, pp. 239-243
-
-
Day, I.P.1
Goudie, J.2
Nishiki, K.3
Williams, P.D.4
-
9
-
-
0027769745
-
Comparison of four basic models of indirect pharmacodynamic responses
-
Dayneka, N. L., V. Garg, and W. J. Jusko. 1993. Comparison of four basic models of indirect pharmacodynamic responses. J. Pharmacokinet. Biopharm. 21:457-478.
-
(1993)
J. Pharmacokinet. Biopharm.
, vol.21
, pp. 457-478
-
-
Dayneka, N.L.1
Garg, V.2
Jusko, W.J.3
-
10
-
-
0031885595
-
Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in rats
-
Della Paschoa, O. E., J. W. Mandema, R. A. Voskuyl, and M. Danhof. 1998. Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in rats. J. Pharmacol. Exp. Ther. 284:460-466.
-
(1998)
J. Pharmacol. Exp. Ther.
, vol.284
, pp. 460-466
-
-
Della Paschoa, O.E.1
Mandema, J.W.2
Voskuyl, R.A.3
Danhof, M.4
-
11
-
-
0033063077
-
Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of fluoroquinolones in rats
-
Delon, A., S. Bouquet, F. Huguet, V. Brunet, P. Courtois, and W. Couet. 1999. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of fluoroquinolones in rats. Antimicrob. Agents Chemother. 43: 1511-1515.
-
(1999)
Antimicrob. Agents Chemother.
, vol.43
, pp. 1511-1515
-
-
Delon, A.1
Bouquet, S.2
Huguet, F.3
Brunet, V.4
Courtois, P.5
Couet, W.6
-
12
-
-
0031000142
-
Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in rats
-
Delon, A., F. Huguet, P. Courtois, J. M. Vierfond, S. Bouquet, and W. Couet. 1997. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in rats. J. Pharmacol. Exp. Ther. 280: 983-987.
-
(1997)
J. Pharmacol. Exp. Ther.
, vol.280
, pp. 983-987
-
-
Delon, A.1
Huguet, F.2
Courtois, P.3
Vierfond, J.M.4
Bouquet, S.5
Couet, W.6
-
13
-
-
0033428350
-
Antagonistic interaction between the convulsant activities of pefloxacin and its main metabolite norfloxacin in rats
-
Delon, A., L. M. Levasseur, M. Giraudon, S. Bouquet, and W. Couet. 1999. Antagonistic interaction between the convulsant activities of pefloxacin and its main metabolite norfloxacin in rats. Pharm. Res. 16:1894-1897.
-
(1999)
Pharm. Res.
, vol.16
, pp. 1894-1897
-
-
Delon, A.1
Levasseur, L.M.2
Giraudon, M.3
Bouquet, S.4
Couet, W.5
-
14
-
-
0028216141
-
Effects of some quinolones on imipenem induced-seizures in DBA/2 mice
-
De Sarro, A., D. Ammendola, and G. De Sarro. 1994. Effects of some quinolones on imipenem induced-seizures in DBA/2 mice. Gen. Pharmacol. 25:369-379.
-
(1994)
Gen. Pharmacol.
, vol.25
, pp. 369-379
-
-
De Sarro, A.1
Ammendola, D.2
De Sarro, G.3
-
15
-
-
0028817342
-
Relationship between structure and convulsant properties of some β-lactam antibiotics following intracerebroventricular microinjection in rats
-
De Sarro, A., D. Ammendola, M. Zappala, S. Grasso, and G. B. De Sarro. 1995. Relationship between structure and convulsant properties of some β-lactam antibiotics following intracerebroventricular microinjection in rats. Antimicrob. Agents Chemother. 39:232-237.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 232-237
-
-
De Sarro, A.1
Ammendola, D.2
Zappala, M.3
Grasso, S.4
De Sarro, G.B.5
-
16
-
-
0028954180
-
Comparative convulsant potencies of two carbapenem derivatives in C57 and DBA/2 mice
-
De Sarro, A., C. Imperatore, P. Mastroeni, and G. De Sarro. 1995. Comparative convulsant potencies of two carbapenem derivatives in C57 and DBA/2 mice. J. Pharm. Pharmacol. 47:292-296.
-
(1995)
J. Pharm. Pharmacol.
, vol.47
, pp. 292-296
-
-
De Sarro, A.1
Imperatore, C.2
Mastroeni, P.3
De Sarro, G.4
-
17
-
-
0031039941
-
Effects of some excitatory amino acid antagonists and drugs enhancing γ-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 mice
-
De Sarro, G., B. F. Nava, G. Calapai, and A. De Sarro. 1997. Effects of some excitatory amino acid antagonists and drugs enhancing γ-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 mice. Antimicrob. Agents Chemother. 41:427-434.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 427-434
-
-
De Sarro, G.1
Nava, B.F.2
Calapai, G.3
De Sarro, A.4
-
18
-
-
0022470510
-
Imipenem-cilastatin. the promise of single agent antimicrobial therapy fulfilled?
-
Dudley, M. N. 1989. Imipenem-cilastatin. The promise of single agent antimicrobial therapy fulfilled? Clin. Pharm. 5:760.
-
(1989)
Clin. Pharm.
, vol.5
, pp. 760
-
-
Dudley, M.N.1
-
19
-
-
0033798131
-
Comparative cerebrospinal fluid diffusion of imipenem and meropenem in rats
-
Dupuis, A., A. Caillaud, C. Pariat, P. Courtois, W. Couet, and S. Bouquet. 2000. Comparative cerebrospinal fluid diffusion of imipenem and meropenem in rats. J. Pharm. Pharmacol. 52:1143-1149.
-
(2000)
J. Pharm. Pharmacol.
, vol.52
, pp. 1143-1149
-
-
Dupuis, A.1
Caillaud, A.2
Pariat, C.3
Courtois, P.4
Couet, W.5
Bouquet, S.6
-
20
-
-
0034074059
-
Imipenem but not meropenem induces convulsions in DBA/2 mice, unrelated to cerebrospinal fluid concentrations
-
Dupuis, A., C. Pariat, P. Courtois, W. Couet, and S. Bouquet. 2000. Imipenem but not meropenem induces convulsions in DBA/2 mice, unrelated to cerebrospinal fluid concentrations. Fundam. Clin. Pharmacol. 14:163-165.
-
(2000)
Fundam. Clin. Pharmacol.
, vol.14
, pp. 163-165
-
-
Dupuis, A.1
Pariat, C.2
Courtois, P.3
Couet, W.4
Bouquet, S.5
-
21
-
-
0003571287
-
-
Swedish Pharmaceutical Press, Stockholm, Sweden
-
Gabrielsson, J., and D. Weiner. 1997. Pharmacokinetic and pharmacodynamic data analysis: concepts and application, 2nd ed. Swedish Pharmaceutical Press, Stockholm, Sweden.
-
(1997)
Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Application, 2nd Ed.
-
-
Gabrielsson, J.1
Weiner, D.2
-
22
-
-
0022642631
-
Cerebrospinal fluid penetration of imipenem and cilastatin (Primaxin) in children with central nervous system infections
-
Jacobs, R. F., G. L. Kearns, A. L. Brown, and D. C. Longee. 1986. Cerebrospinal fluid penetration of imipenem and cilastatin (Primaxin) in children with central nervous system infections. Antimicrob. Agents Chemother. 29: 670-674.
-
(1986)
Antimicrob. Agents Chemother.
, vol.29
, pp. 670-674
-
-
Jacobs, R.F.1
Kearns, G.L.2
Brown, A.L.3
Longee, D.C.4
-
23
-
-
0027943266
-
Physiologic indirect response models characterize diverse types of pharmacodynamic effects
-
Jusko, W. J., and H. C. Ko. 1994. Physiologic indirect response models characterize diverse types of pharmacodynamic effects. Clin. Pharmacol. Ther. 56:406-419.
-
(1994)
Clin. Pharmacol. Ther.
, vol.56
, pp. 406-419
-
-
Jusko, W.J.1
Ko, H.C.2
-
24
-
-
0025827837
-
Seizure activity associated with imipenem use: Clinical case reports and review of the literature
-
Leo, R. J., and C. H. Ballow. 1991. Seizure activity associated with imipenem use: clinical case reports and review of the literature. DICP Ann, Pharmacother. 25:351-354.
-
(1991)
DICP Ann, Pharmacother.
, vol.25
, pp. 351-354
-
-
Leo, R.J.1
Ballow, C.H.2
-
25
-
-
0031817728
-
Development of a new quantitative approach for the isobolographic assessment of the convulsant interaction between pefloxacin and theophylline in rats
-
Levasseur, L. M., A. Delon, W. R. Greco, P. Faury, S. Bouquet, and W. Couet. 1998. Development of a new quantitative approach for the isobolographic assessment of the convulsant interaction between pefloxacin and theophylline in rats. Pharm. Res. 15:1069-1076.
-
(1998)
Pharm. Res.
, vol.15
, pp. 1069-1076
-
-
Levasseur, L.M.1
Delon, A.2
Greco, W.R.3
Faury, P.4
Bouquet, S.5
Couet, W.6
-
26
-
-
0026058369
-
Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: Influence of rate and route of administration
-
Mandema, J. W., E. Tukker, and M. Danhof. 1991. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration. Br. J. Pharmacol. 102:663-668.
-
(1991)
Br. J. Pharmacol.
, vol.102
, pp. 663-668
-
-
Mandema, J.W.1
Tukker, E.2
Danhof, M.3
-
27
-
-
0034002147
-
Pharmacokinetic-pharmacodynamic modelling of the convulsant interaction between norfloxacin and biphenyl acetic acid in rats
-
Marchand, S., C. Pariat, S. Bouquet, P. Courtois, and W. Couet. 2000. Pharmacokinetic-pharmacodynamic modelling of the convulsant interaction between norfloxacin and biphenyl acetic acid in rats. Brit. J. Pharmacol. 129:1609-1616.
-
(2000)
Brit. J. Pharmacol.
, vol.129
, pp. 1609-1616
-
-
Marchand, S.1
Pariat, C.2
Bouquet, S.3
Courtois, P.4
Couet, W.5
-
28
-
-
0022408794
-
Penetration of imipenem and cilastatin into cerebrospinal fluid of patients with bacterial meningitis
-
Modai, J., D. Vittecoq, J. M. Decazes, and A. Meulemans. 1985. Penetration of imipenem and cilastatin into cerebrospinal fluid of patients with bacterial meningitis. J. Antimicrob. Chemother. 16:751-755.
-
(1985)
J. Antimicrob. Chemother.
, vol.16
, pp. 751-755
-
-
Modai, J.1
Vittecoq, D.2
Decazes, J.M.3
Meulemans, A.4
-
29
-
-
0029823378
-
Neurotoxicity of carbapenem antibacterials
-
Norrby, R. S. 1996. Neurotoxicity of carbapenem antibacterials. Drug Saf. 15:87-90.
-
(1996)
Drug Saf.
, vol.15
, pp. 87-90
-
-
Norrby, R.S.1
-
30
-
-
0024415132
-
Meropenem: Evidence of lack of proconvulsive tendency in mice
-
Patel, J. B., and R. E. Giles. 1989. Meropenem: evidence of lack of proconvulsive tendency in mice. J. Antimicrob. Chemother. 24(Suppl. A):307-309.
-
(1989)
J. Antimicrob. Chemother.
, vol.24
, Issue.SUPPL. A
, pp. 307-309
-
-
Patel, J.B.1
Giles, R.E.2
-
31
-
-
0021921241
-
Kinetics of drug action in disease states. XIV. Effect of infusion rate on pentylenetetrazol concentrations in serum, brain and cerebrospinal fluid of rats at onset of convulsions
-
Ramzan, I. M., and G. Levy. 1985. Kinetics of drug action in disease states. XIV. Effect of infusion rate on pentylenetetrazol concentrations in serum, brain and cerebrospinal fluid of rats at onset of convulsions. J. Pharmacol. Exp. Ther. 234:624-628.
-
(1985)
J. Pharmacol. Exp. Ther.
, vol.234
, pp. 624-628
-
-
Ramzan, I.M.1
Levy, G.2
-
32
-
-
0022491959
-
Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline induced seizures in rats
-
Ramzan, I. M., and G. Levy. 1986. Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline induced seizures in rats. J. Pharmacol. Exp. Ther. 236:708-713.
-
(1986)
J. Pharmacol. Exp. Ther.
, vol.236
, pp. 708-713
-
-
Ramzan, I.M.1
Levy, G.2
-
33
-
-
0025828473
-
Neurotoxicity of β-lactam: Predisposing factors and pathogenesis
-
Schliamser, S. E., O. Cars, and S. R. Norrby. 1991. Neurotoxicity of β-lactam: predisposing factors and pathogenesis. J. Antimicrob. Chemother. 27: 405-425.
-
(1991)
J. Antimicrob. Chemother.
, vol.27
, pp. 405-425
-
-
Schliamser, S.E.1
Cars, O.2
Norrby, S.R.3
-
34
-
-
0030429755
-
Characterization of four basic models of indirect pharmacodynamic responses
-
Sharma, A., and W. J. Jusko. 1996. Characterization of four basic models of indirect pharmacodynamic responses. J. Pharmacokinet. Biopharm. 24:611-635.
-
(1996)
J. Pharmacokinet. Biopharm.
, vol.24
, pp. 611-635
-
-
Sharma, A.1
Jusko, W.J.2
-
35
-
-
0018394195
-
Simultaneous modelling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine
-
Sheiner, L. B., D. R. Stanski, S. Vozeh, R. D. Miller, and J. Ham. 1979. Simultaneous modelling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin. Pharmacol. Ther. 25:358-371.
-
(1979)
Clin. Pharmacol. Ther.
, vol.25
, pp. 358-371
-
-
Sheiner, L.B.1
Stanski, D.R.2
Vozeh, S.3
Miller, R.D.4
Ham, J.5
-
36
-
-
0029046103
-
Structural features resulting in convulsive activity of carbapenem compounds: Effect of C-2 side chain
-
Sunagawa, M., H. Matsumura, Y. Sumita, and H. Nouda. 1995. Structural features resulting in convulsive activity of carbapenem compounds: effect of C-2 side chain. J. Antibiot. 48:408-416.
-
(1995)
J. Antibiot.
, vol.48
, pp. 408-416
-
-
Sunagawa, M.1
Matsumura, H.2
Sumita, Y.3
Nouda, H.4
-
37
-
-
0023279701
-
Seizure-like activity associated with imipenem-cilastatin
-
Tse, C. S. T., F. H. Vera, and D. V. Desai. 1987. Seizure-like activity associated with imipenem-cilastatin. Drug Intell. Clin. Pharm. 21:659-660.
-
(1987)
Drug Intell. Clin. Pharm.
, vol.21
, pp. 659-660
-
-
Tse, C.S.T.1
Vera, F.H.2
Desai, D.V.3
-
38
-
-
0031881728
-
The time of maximum effect for model selection in pharmacokinetic-pharmacodynamic analysis applied to frusemide
-
Wakelkamp, M., G. Alvan, and G. Paintaud. 1998. The time of maximum effect for model selection in pharmacokinetic-pharmacodynamic analysis applied to frusemide. Br. J. Clin. Pharmacol. 45:63-70.
-
(1998)
Br. J. Clin. Pharmacol.
, vol.45
, pp. 63-70
-
-
Wakelkamp, M.1
Alvan, G.2
Paintaud, G.3
-
39
-
-
0030747113
-
Antibiotic-induced convulsions
-
Wallace, K. L. 1997. Antibiotic-induced convulsions. Crit. Care Clin. 13:741-762.
-
(1997)
Crit. Care Clin.
, vol.13
, pp. 741-762
-
-
Wallace, K.L.1
-
40
-
-
0023947514
-
Animal model for evaluating the convulsive liability of β-lactam antibiotics
-
Williams, P. D., D. B. Bennett, and C. R. Comereski. 1988. Animal model for evaluating the convulsive liability of β-lactam antibiotics. Antimicrob. Agents Chemother. 32:758-760.
-
(1988)
Antimicrob. Agents Chemother.
, vol.32
, pp. 758-760
-
-
Williams, P.D.1
Bennett, D.B.2
Comereski, C.R.3
-
41
-
-
0026073751
-
Imipenem/cilastatin treatment of bacterial meningitis in children
-
Wong, V. K., H. T. Wright, L. A. Ross, W. H. Mason, C. B. Inderlied, and K. S. Kim. 1991. Imipenem/cilastatin treatment of bacterial meningitis in children. Pediatr. Infect. Dis. J. 10:122-125.
-
(1991)
Pediatr. Infect. Dis. J.
, vol.10
, pp. 122-125
-
-
Wong, V.K.1
Wright, H.T.2
Ross, L.A.3
Mason, W.H.4
Inderlied, C.B.5
Kim, K.S.6
|